CSIMarket Company Name, Ticker, Competitors, else..


Transmedics Group Inc   (NASDAQ: TMDX)
Other Ticker:  
 

Transmedics Group Inc

TMDX's Fundamental analysis



Looking into Transmedics Group Inc growth rates, revenue grew by 48.21 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 406

Medical Equipment & Supplies industry recorded deterioration of revenues by -3.26 %

Transmedics Group Inc 's net income grew by 110.56 % in first quarter of 2025 year on year, above company average,

• More on TMDX's Growth


Transmedics Group Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Transmedics Group Inc PEG ratio is at -0.22 Transmedics Group Inc realized cash reduction of $ -1 per share in trailing twelve-month period.
Company
105.91
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.68.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.


• More on TMDX's Valuation
 
 Total Debt (Millions $) 510
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 2,516,634
 Net Income/Employee (TTM) $ 252,314
 Receivable Turnover (TTM) 4.75
 Tangible Book Value (Per Share $) 6.33

Transmedics Group Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Transmedics Group Inc PEG ratio is at -0.22 Transmedics Group Inc realized cash outflow of $ -1per share in trailing twelve-month period.
Company
105.91
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11.68.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.

Transmedics Group Inc Price to Book Ratio is at 21.41 higher than Industry Avg. of -500.27, and higher than S&P 500 Avg. of 0.01

• More on TMDX's Valuation

•  Market Capitalization (Millions $) 5,703
•  Shares Outstanding (Millions) 40
•  Employees 194
•  Revenues (TTM) (Millions $) 488
•  Net Income (TTM) (Millions $) 49
•  Cash Flow (TTM) (Millions $) -40
•  Capital Exp. (TTM) (Millions $) -113
•  Total Debt (Millions $) 510
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 2,516,634
•  Net Income/Employee(TTM) $ 252,314
•  Receivable Turnover Ratio (TTM) 4.75
•  Tangible Book Value (Per Share $) 6.33

•  Market Capitalization (Millions $) 5,703
•  Shares Outstanding (Millions) 40
•  Employees 194
•  Revenues (TTM) (Millions $) 488
•  Net Income (TTM) (Millions $) 49
•  Cash Flow (TTM) (Millions $) -40
•  Capital Exp. (TTM) (Millions $) -113


    TMDX's Profitability Comparisons
Transmedics Group Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 19.12 % from 7.11 % in IV. Quarter.

Transmedics Group Inc net profit margin of 17.89 % is currently ranking no. 13 in Medical Equipment & Supplies industry, ranking no. 61 in Healthcare sector and number 750 in S&P 500.


Profitability by Segment
Total 17.89 %



  Ratio
•   Capital Ratio (MRQ) 9.1
•  Total Debt to Equity (MRQ) 1.92
•  Tangible Leverage Ratio (MRQ) 2.24
•  Asset Turnover Ratio (TTM) 0.61
•  Inventory Turnover Ratio (TTM) 4.15



Transmedics Group Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 19.12 % from 7.11 % in IV. Quarter.

Transmedics Group Inc net profit margin of 17.89 % is currently ranking no. 13 in Medical Equipment & Supplies industry, ranking no. 61 in Healthcare sector and number 750 in S&P 500.

• More on TMDX's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com